Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

NCT07195682

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

SCRI Oncology Partners Nashville, Tennessee, United States

View Trial Details

Recruiting

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

NCT07037004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Recruiting

Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment

NCT07524426

Conditions: Bladder Cancer (BC), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Norrlands University Hosital Umeå, Västerbotten County, Sweden

View Trial Details

Recruiting

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

NCT07225114

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +17 more
Locations: The University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

NCT06026410

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States

University of Arizona Tucson, Arizona, United States

University of Southern California Los Angeles, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

View all 38 locations

View Trial Details

Recruiting

ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses

NCT06722807

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

NCT05765084

Conditions: Adenoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +26 more
Locations: Antwerp University Hospital Edegem, Antwerp, Belgium

AZ Maria Middelares Ghent, Belgium

VITAZ Sint-Niklaas, Belgium

View Trial Details

Recruiting

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT07510334

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

NCT07018037

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: "Regina Elena" National Cancer Institute Rome, Italy

View Trial Details

Recruiting

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

NCT04235777

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +20 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions